These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8554885)

  • 21. [Dose-effect measurements as a basis for computer-assisted dose distribution planning in brachytherapy].
    Fichte B; Schumann E
    Strahlentherapie; 1984 May; 160(5):324-7. PubMed ID: 6729867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
    Nickers P; Thissen B; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Concept of the nominal standard dosage as applied to the intracavitary therapy of oncological gynecologic patients using 60Co and 252Cf].
    Nikishin BK; Gaponenko ED; Koval' GN; Abdullaev VD
    Med Radiol (Mosk); 1979 Dec; 24(12):53-7. PubMed ID: 514002
    [No Abstract]   [Full Text] [Related]  

  • 24. Advantages and limitations of radioactive stents.
    Hehrlein C; Kübler W
    Semin Interv Cardiol; 1997 Jun; 2(2):109-13. PubMed ID: 9546990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chest wall dose in MammoSite breast brachytherapy: radiobiologic estimations of late complication risk based on dose-volume considerations.
    Dragun AE; Aguero EG; Harmon JF; Harper JL; Jenrette JM
    Brachytherapy; 2005; 4(4):259-63. PubMed ID: 16344255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality assurance tool for determination of position and transit time of a Co-60 source in high dose rate brachytherapy.
    Píriz GH; Ortega-Spina HG; González-Sprinberg GA
    Appl Radiat Isot; 2021 Dec; 178():109971. PubMed ID: 34653879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer.
    DuBeshter B; Estler K; Altobelli K; McDonald S; Glantz C; Angel C
    Gynecol Oncol; 2004 Aug; 94(2):383-6. PubMed ID: 15297176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
    Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study.
    Pinkawa M; Fischedick K; Treusacher P; Asadpour B; Gagel B; Piroth MD; Borchers H; Jakse G; Eble MJ
    Radiother Oncol; 2006 Jan; 78(1):41-6. PubMed ID: 16271785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of the combination of external radiotherapy and curietherapy in carcinoma of the velo-tonsillar region. Statistical study of a series of 361 patients].
    Pernot M; Hoffstetter S; Malissard L; Luporsi E; Peiffert D; Aletti P; Marchal C; Kozminski P; Bey P
    Bull Cancer Radiother; 1996; 83(1):40-6. PubMed ID: 8679280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
    Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dosage determination in the intracavity radiation therapy of uterine tumors with the AGAT-B apparatus].
    Minchenkova EA
    Med Radiol (Mosk); 1991; 36(3):47-8. PubMed ID: 2017006
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
    Fang FM; Wang YM; Wang CJ; Huang HY; Chiang PH
    Jpn J Clin Oncol; 2008 Jul; 38(7):474-9. PubMed ID: 18621848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Monte Carlo brachytherapy study for dose distribution prediction in an inhomogeneous medium.
    Slate LJ; Elson HR; Lamba MA; Kassing WM; Soldano M; Barrett WL
    Med Dosim; 2004; 29(4):271-8. PubMed ID: 15528069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma.
    Bourgier C; Coche-Déquéant B; Fournier C; Castelain B; Prévost B; Lefebvre JL; Lartigau E
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):434-40. PubMed ID: 16168836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Broad-beam transmission data for new brachytherapy sources, Tm-170 and Yb-169.
    Granero D; Pérez-Calatayud J; Ballester F; Bos AJ; Venselaar J
    Radiat Prot Dosimetry; 2006; 118(1):11-5. PubMed ID: 16030058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose distribution for endovascular brachytherapy using Ir-192 sources: comparison of Monte Carlo calculations with radiochromic film measurements.
    Sureka CS; Sunny CS; Subbaiah KV; Aruna P; Ganesan S
    Phys Med Biol; 2007 Jan; 52(2):525-37. PubMed ID: 17202631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Four year clinical statistics of iridium-192 high dose rate brachytherapy.
    Shigehara K; Mizokami A; Komatsu K; Koshida K; Namiki M
    Int J Urol; 2006 Feb; 13(2):116-21. PubMed ID: 16563134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nerve tolerance to high-dose-rate brachytherapy in patients with soft tissue sarcoma: a retrospective study.
    Kubo T; Sugita T; Shimose S; Matsuo T; Hirao K; Kimura H; Kenjo M; Ochi M
    BMC Cancer; 2005 Jul; 5():79. PubMed ID: 16026629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current possibilities of utilizing covert sources of radiation in brachytherapy for neoplasia].
    Kanaev SV; Turkevich VG
    Vopr Onkol; 2007; 53(6):690-5. PubMed ID: 18416139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.